Treatment strategies for bronchial asthma: an update.
Advances in understanding the biomolecular basis of the disease's inflammatory and remodeling responses are offering new therapeutic choices--and sometimes new drug-delivery systems--in categories such as beta-agonists, glucocorticoids, and leukotriene blockers. Meanwhile, researchers are exploring novel targets, including intercellular signals and cell-adhesion and gene-activating molecules.